Results 131 to 140 of about 48,863 (239)

A phase 1, multicenter, open‐label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 202-212, January 2026.
Abstract Objective To evaluate pharmacokinetics (PK), safety, and tolerability of a weight‐adjusted dose of rimegepant orally disintegrating tablet (ODT) in children (aged ≥6 to <12 years) with a history of migraine. Background Rimegepant 75 mg ODT is approved for acute treatment of migraine (with or without aura) and preventive treatment of episodic ...
Chay Ngee Lim   +9 more
wiley   +1 more source

Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025

open access: yesHIV Medicine, Volume 27, Issue 1, Page 18-32, January 2026.
Abstract Background The European AIDS Clinical Society (EACS) guidelines were revised for the 21st time in 2025, with updates covering all aspects of HIV care. Key Points of the Guidelines Update The structure of the guidelines has been reorganized into two parts: Part I focuses on the management and prevention of HIV and related infections, and Part ...
Juan Ambrosioni   +19 more
wiley   +1 more source

Dupilumab facial redness: Positive effect of itraconazole [PDF]

open access: gold, 2019
Fleur S.A. de Beer   +6 more
openalex   +1 more source

Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategies

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 1, Page 29-45, January 2026.
There is a concerning trend of widespread and severe superficial fungal infections caused by a new pathogen—Trichophyton indotineae—resistant to standard antifungal therapies. T. indotineae is now spreading globally and evolving. There is increasing urgency for healthcare providers and policy makers to initiate surveillance systems and antifungal ...
Aditya K. Gupta   +11 more
wiley   +1 more source

A Trial of Itraconazole or Amphotericin B for HIV‐Associated Talaromycosis

open access: yesNew England Journal of Medicine, 2017
T. Le   +23 more
semanticscholar   +1 more source

Study on Usefulness of Novel Itraconazole Solid Dispersion when Administered as a Suspension

open access: bronze, 2008
Takao Oshima   +6 more
openalex   +2 more sources

Stereospecific Metabolism of Itraconazole by CYP3A4: Dioxolane Ring Scission of Azole Antifungals [PDF]

open access: bronze, 2011
Chi-Chi Peng   +6 more
openalex   +1 more source

A Cross‐Sectional Study to Determine Candida spp. Carriage in Libyan Patients With Type 2 Diabetes

open access: yesBioMed Research International, Volume 2026, Issue 1, 2026.
The risk for Candida infections in patients with diabetes mellitus (DM) is three times higher than in the general population. Despite a DM prevalence of 15.8% reported in Libya (2024), the laboratory identification and susceptibility testing of fungal infections in patients with DM are not routinely performed.
Mustafa H. M. Esmaio   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy